Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 121

1.

Response of relapsed central nervous system hairy cell leukemia to vemurafenib.

McDowell MM, Zhu X, Agarwal N, Nikiforova MN, Lieberman FS, Drappatz J.

Leuk Lymphoma. 2016 Apr 27:1-3. [Epub ahead of print] No abstract available.

PMID:
27116997
2.

Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors.

Nikiforov YE, Seethala RR, Tallini G, Baloch ZW, Basolo F, Thompson LD, Barletta JA, Wenig BM, Al Ghuzlan A, Kakudo K, Giordano TJ, Alves VA, Khanafshar E, Asa SL, El-Naggar AK, Gooding WE, Hodak SP, Lloyd RV, Maytal G, Mete O, Nikiforova MN, Nosé V, Papotti M, Poller DN, Sadow PM, Tischler AS, Tuttle RM, Wall KB, LiVolsi VA, Randolph GW, Ghossein RA.

JAMA Oncol. 2016 Apr 14. doi: 10.1001/jamaoncol.2016.0386. [Epub ahead of print]

PMID:
27078145
3.

Prevalence and phenotypic correlations of EIF1AX mutations in thyroid nodules.

Karunamurthy A, Panebianco F, J Hsiao S, Vorhauer J, Nikiforova MN, Chiosea S, Nikiforov YE.

Endocr Relat Cancer. 2016 Apr;23(4):295-301. doi: 10.1530/ERC-16-0043. Epub 2016 Feb 24.

PMID:
26911375
4.

Next-Generation Sequencing Informatics.

Roy S, LaFramboise WA, Nikiforov YE, Nikiforova MN, Routbort MJ, Pfeifer J, Nagarajan R, Carter AB, Pantanowitz L.

Arch Pathol Lab Med. 2016 Feb 22. [Epub ahead of print]

PMID:
26901284
5.

Characterizing Molecular Variants and Clinical Utilization of Next-generation Sequencing in Advanced Breast Cancer.

Gurda GT, Ambros T, Nikiforova MN, Nikiforov YE, Lucas PC, Dabbs DJ, Lee AV, Brufsky AM, Puhalla SL, Bhargava R.

Appl Immunohistochem Mol Morphol. 2016 Feb 9. [Epub ahead of print]

PMID:
26862949
6.

Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival.

Olevian DC, Nikiforova MN, Chiosea S, Sun W, Bahary N, Kuan SF, Pai RK.

Hum Pathol. 2016 Mar;49:124-34. doi: 10.1016/j.humpath.2015.11.004. Epub 2015 Nov 17.

PMID:
26826419
7.

NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States.

Prasad ML, Vyas M, Horne MJ, Virk RK, Morotti R, Liu Z, Tallini G, Nikiforova MN, Christison-Lagay ER, Udelsman R, Dinauer CA, Nikiforov YE.

Cancer. 2016 Apr 1;122(7):1097-107. doi: 10.1002/cncr.29887. Epub 2016 Jan 19.

PMID:
26784937
8.

A Multiplexed Amplicon Approach for Detecting Gene Fusions by Next-Generation Sequencing.

Beadling C, Wald AI, Warrick A, Neff TL, Zhong S, Nikiforov YE, Corless CL, Nikiforova MN.

J Mol Diagn. 2016 Mar;18(2):165-75. doi: 10.1016/j.jmoldx.2015.10.002. Epub 2015 Dec 30.

PMID:
26747586
9.

Targeted Next-Generation Sequencing Analysis of a Pendred Syndrome-Associated Thyroid Carcinoma.

Tong GX, Chang Q, Hamele-Bena D, Carew J, Hoffman RS, Nikiforova MN, Nikiforov YE.

Endocr Pathol. 2016 Mar;27(1):70-5. doi: 10.1007/s12022-015-9413-4.

PMID:
26744121
10.

American Gastroenterological Association guidelines are inaccurate in detecting pancreatic cysts with advanced neoplasia: a clinicopathologic study of 225 patients with supporting molecular data.

Singhi AD, Zeh HJ, Brand RE, Nikiforova MN, Chennat JS, Fasanella KE, Khalid A, Papachristou GI, Slivka A, Hogg M, Lee KK, Tsung A, Zureikat AH, McGrath K.

Gastrointest Endosc. 2016 Jun;83(6):1107-1117.e2. doi: 10.1016/j.gie.2015.12.009. Epub 2015 Dec 18.

PMID:
26709110
11.

Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors.

Nikiforova MN, Wald AI, Melan MA, Roy S, Zhong S, Hamilton RL, Lieberman FS, Drappatz J, Amankulor NM, Pollack IF, Nikiforov YE, Horbinski C.

Neuro Oncol. 2016 Mar;18(3):379-87. doi: 10.1093/neuonc/nov289. Epub 2015 Dec 17.

PMID:
26681766
12.

Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer Patients.

Wang P, Bahreini A, Gyanchandani R, Lucas PC, Hartmaier RJ, Watters RJ, Jonnalagadda AR, Trejo Bittar HE, Berg A, Hamilton RL, Kurland BF, Weiss KR, Mathew A, Leone JP, Davidson NE, Nikiforova MN, Brufsky AM, Ambros TF, Stern AM, Puhalla SL, Lee AV, Oesterreich S.

Clin Cancer Res. 2016 Mar 1;22(5):1130-7. doi: 10.1158/1078-0432.CCR-15-1534. Epub 2015 Oct 23.

PMID:
26500237
13.

Histopathologic and Clinical Characterization of Thyroid Tumors Carrying the BRAF(K601E) Mutation.

Afkhami M, Karunamurthy A, Chiosea S, Nikiforova MN, Seethala R, Nikiforov YE, Coyne C.

Thyroid. 2016 Feb;26(2):242-7. doi: 10.1089/thy.2015.0227. Epub 2015 Dec 17.

PMID:
26422023
14.

Molecular Characterization of Sporadic Pediatric Thyroid Carcinoma with the DNA/RNA ThyroSeq v2 Next-Generation Sequencing Assay.

Picarsic JL, Buryk MA, Ozolek J, Ranganathan S, Monaco SE, Simons JP, Witchel SF, Gurtunca N, Joyce J, Zhong S, Nikiforova MN, Nikiforov YE.

Pediatr Dev Pathol. 2016 Mar-Apr;19(2):115-22. doi: 10.2350/15-07-1667-OA.1. Epub 2015 Sep 14.

PMID:
26367451
15.

Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology.

Nikiforov YE, Carty SE, Chiosea SI, Coyne C, Duvvuri U, Ferris RL, Gooding WE, LeBeau SO, Ohori NP, Seethala RR, Tublin ME, Yip L, Nikiforova MN.

Thyroid. 2015 Nov;25(11):1217-23. doi: 10.1089/thy.2015.0305. Epub 2015 Sep 10.

16.

Clinicopathological comparison of colorectal and endometrial carcinomas in patients with Lynch-like syndrome versus patients with Lynch syndrome.

Mas-Moya J, Dudley B, Brand RE, Thull D, Bahary N, Nikiforova MN, Pai RK.

Hum Pathol. 2015 Nov;46(11):1616-25. doi: 10.1016/j.humpath.2015.06.022. Epub 2015 Jul 8.

PMID:
26319271
17.

Primary RET-mutated lung neuroendocrine carcinoma in MEN2B: response to RET-targeted therapy.

Geiger JL, Chiosea SI, Challinor SM, Nikiforova MN, Bauman JE.

Endocr Relat Cancer. 2015 Oct;22(5):L19-22. doi: 10.1530/ERC-15-0307. Epub 2015 Aug 18. No abstract available.

PMID:
26285607
18.

Mutations of TSHR and TP53 Genes in an Aggressive Clear Cell Follicular Carcinoma of the Thyroid.

Tong GX, Mody K, Wang Z, Hamele-Bena D, Nikiforova MN, Nikiforov YE.

Endocr Pathol. 2015 Dec;26(4):315-9. doi: 10.1007/s12022-015-9388-1.

PMID:
26260781
19.

Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patients.

Yip L, Nikiforova MN, Yoo JY, McCoy KL, Stang MT, Armstrong MJ, Nicholson KJ, Ohori NP, Coyne C, Hodak SP, Ferris RL, LeBeau SO, Nikiforov YE, Carty SE.

Ann Surg. 2015 Sep;262(3):519-25; discussion 524-5. doi: 10.1097/SLA.0000000000001420.

PMID:
26258321
20.

Significance of what is not sampled: Characteristics of thyroid nonmicrocarcinomas (>1.0 cm) that were not targeted.

Schoedel KE, Wolfe J, Hodak SP, Lebeau SO, Yip L, Carty SE, Nikiforova MN, Nikiforov YE, Ohori NP.

Cancer Cytopathol. 2015 Nov;123(11):678-83. doi: 10.1002/cncy.21603. Epub 2015 Aug 4.

PMID:
26242638
Items per page

Supplemental Content

Loading ...
Write to the Help Desk